All In Biotech

Drug Trial Radar · NCT05011383

High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

High-dose Testosterone in Men With Metastatic Castration-resistant Prostate Cancer and ATM or CDK12 Deficiency

Last checked: Nov 20, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

51

Planned (sponsor's estimate)

Start

Aug 31, 2021

Primary completion

Aug 3, 2027

Study completion Aug 31, 2027

Sponsor

Lead sponsor
VA Office of Research and DevelopmentFederal agency
Sponsor type
Federal agency
First posted
Aug 18, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Male only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will determine whether the presence of DNA repair deficiency in the form of alterations in the genes ATM, CDK12 or CHEK2 predicts for a high likelihood of responding to the use of intermittent high dose testosterone. This therapy may result in responses in tumors which are genetically unstable because of DNA repair deficiency and this is a prospective study to test that hypothesis

Conditions

  • Metastatic Prostate Cancer

Interventions

  • High dose testosteroneDrug

    High dose testosterone is administered subcutaneously once monthly until progression or toxicity

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. PSA responseTime frame: 12 weeks

Locations

17 sites in 1 country. Site status is shown where the registry gives one.

  • Rocky Mountain Regional VA Medical Center, Aurora, CO

    Aurora, Colorado · Recruiting

  • VA Connecticut Healthcare System West Haven Campus, West Haven, CT

    West Haven, Connecticut · Recruiting

  • North Florida/South Georgia Veterans Health System, Gainesville, FL

    Gainesville, Florida · Recruiting

  • Orlando VA Medical Center, Orlando, FL

    Orlando, Florida · Recruiting

  • Atlanta VA Medical and Rehab Center, Decatur, GA

    Decatur, Georgia · Recruiting

  • Robley Rex VA Medical Center, Louisville, KY

    Louisville, Kentucky · Recruiting

  • Kansas City VA Medical Center, Kansas City, MO

    Kansas City, Missouri · Recruiting

  • St. Louis VA Medical Center John Cochran Division, St. Louis, MO

    St Louis, Missouri · Recruiting

  • Durham VA Medical Center, Durham, NC

    Durham, North Carolina · Recruiting

  • Salisbury W.G. (Bill) Hefner VA Medical Center, Salisbury, NC

    Salisbury, North Carolina · Recruiting

  • VA Portland Health Care System, Portland, OR

    Portland, Oregon · Recruiting

  • Ralph H. Johnson VA Medical Center, Charleston, SC

    Charleston, South Carolina · Recruiting

  • Memphis VA Medical Center, Memphis, TN

    Memphis, Tennessee · Recruiting

  • Tennessee Valley Healthcare System Nashville Campus, Nashville, TN

    Nashville, Tennessee · Recruiting

  • Michael E. DeBakey VA Medical Center, Houston, TX

    Houston, Texas · Not yet recruiting

  • VA Puget Sound Health Care System Seattle Division, Seattle, WA

    Seattle, Washington · Recruiting

  • William S. Middleton Memorial Veterans Hospital, Madison, WI

    Madison, Wisconsin · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.